Prognostic significance of PET/CT for CAR T cell therapy in relapsed/refractory multiple myeloma.

Hemasphere · 2025 · PMC12167625 · PMID 40519771

Europe PMC DOI

hedged sentence

0.0700

closest p · 1.4× alpha

0.0700

boldest claim

The sentences

showed a trendp = 0.07so close (0.05 < p ≤ 0.1)

Double‐negative patients (metCR and serological CR) showed a trend toward improved PFS ( p = 0.07, Figure 3C ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.